Circulating cancer associated fibroblast and cancer stem cell markers as diagnostic and prognostic tools of hepatitis C induced hepatocellular carcinoma

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Elzallat M.; Zoheiry M.; El-Ahwany E.; Abu-Taleb H.; Hassan M.; Madkour L.N.; Mabrouk R.R.; El Talkawy M.D.; Taha S.A.; Abd –Elaziz D.M.

Journal: Egyptian Pharmaceutical Journal

Publisher: National Information and Documentation Center (NIDOC) Academy of Scientific Research and Technology

Publication Date: 24 August 2025

Volume / Issue: Volume 24 / Issue 4

Pages: 49–61

ISSN: 16874315

DOI: 10.21608/epj.2025.355774.1027

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Bronze Open Access


Authors and Affiliations

Elzallat M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Zoheiry M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; El-Ahwany E., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Abu-Taleb H., Enviromental Research Department, Theodor Bilharz Research Institute, Giza, Egypt; Hassan M., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Madkour L.N., Immunology Department, Theodor Bilharz Research Institute, Giza, Egypt; Mabrouk R.R., Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; El Talkawy M.D., Hepatogastroenterology Department, Theodor Bilharz Research Institute, Giza, Egypt; Taha S.A., Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Abd –Elaziz D.M., Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt


Abstract

Background Several studies have been carried out on the crosstalk between cancer-associated fibroblasts (CAFs) and liver cancer stem cells (LCSCs) and their roles in tumorigenesis and metastasis in various malignancies, including hepatocellular carcinoma (HCC). Identification of cancer stem cells (CSCs) and CAFs in these studies has typically been carried out based on their markers' expression in hepatic tumor tissues. Objective To detect CAFs and CSCs markers in peripheral blood, which can be used as non-invasive diagnostic and prognostic tools for HCV induced fibrosis and carcinogenesis in Egyptian patients. Materials and methods A case-control study was conducted on 200 subjects. Four groups were included in the study: A) healthy control group, B) chronic hepatitis C (CHC) non-cirrhotic group, C) CHC-cirrhotic group and, D) CHC-HCC group. Peripheral blood detection of LCSC markers (CD133&CD44) was done by Flow-cytometer analysis, and ELISA was used to detect CAFs markers such as Collagen Type XI Alpha I Chain (COL11A1) and α-smooth muscle actin (α-SMA). Results and conclusion Significant difference in the level of CD133, CD44 and COL11A1 in CHC patients compared to the control group (<0.001). The level of previous markers increased with the progression of the disease. However, α-SMA level decreased in both the non-cirrhotic and HCC groups. Sensitivity of CD133 was 77.78% with specificity 88.24% followed by COL11A1 with higher sensitivity of 83.33%, but a slightly lower specificity of 73.33%. So, CD133 emerged as the most promising diagnostic marker for HCC, followed by COL11A1. Regular detection of CSCs and CAFs in circulation may aid in the diagnosis and prognosis of liver cirrhosis and HCC. © 2025 Egyptian Pharmaceutical Journal.


Keywords

cancer associated fibroblasts; cancer stem cells; hepatitis C infection; Hepatocellular carcinoma; alpha actin; CD133 antigen; cell marker; collagen type 11; Hermes antigen; adult; Article; cancer associated fibroblast; cancer prognosis; cancer stem cell; case control study; controlled study; enzyme linked immunosorbent assay; female; hepatitis C; human; liver cell carcinoma; major clinical study; male; sensitivity and specificity


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]